Sacubitril Production Cost Reports

The report provides a detailed analysis essential for establishing a Sacubitril production plant. It encompasses all critical aspects necessary for Sacubitril production, including the cost of Sacubitril production, Sacubitril plant cost, Sacubitril production costs, and the overall Sacubitril production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Sacubitril production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Sacubitril is a neprilysin inhibitor that is combined with Valsartan to manage various forms of chronic heart failure. It improves the body's natural natriuretic peptide system, which promotes vasodilation to lower blood pressure. It increases diuresis to reduce fluid overload and stops cardiac remodelling to ease the heart's workload, which decreases the risks of cardiovascular death and hospitalisation.

This combination is FDA-approved for adults with heart failure with reduced ejection fraction, heart failure with preserved ejection fraction and pediatric patients over 1 year old. It is also used in post-myocardial infarction cardio protection, chemotherapy-induced cardiomyopathy in cardio-oncology, and in myocarditis.

The market for Sacubitril is influenced by increasing cases of cardiovascular diseases like heart failure and hypertension. The demand for advanced ARNI therapies and their ability to reduce mortality and hospitalisations boost their demand. The rise in ageing populations, increasing healthcare spending, favourable reimbursement policies, and R&D for formulations enhancing bioavailability make it a popular medication.

The industrial Sacubitril procurement is influenced by API high purity standards, strict regulatory compliance (GMP, USDMF, CEP, JDMF), and reliable suppliers from China and India. The fluctuating prices because of raw materials, synthesis complexity, supply chain disruptions, geopolitical risks, and competition from generics further impact its sourcing.

Raw Material for Sacubitril Production

According to the Sacubitril production plant project report, the key raw materials used in the production of Sacubitril include 4-biphenylboronic acid pinacol ester, bromo intermediate, and succinic anhydride.

Production Process of Sacubitril

The extensive Sacubitril production cost report consists of the following major industrial production process:

1. From 4-biphenylboronic acid pinacol ester: The Sacubitril production involves Suzuki coupling of a bromo-protected amino acid derivative with 4-biphenylboronic acid pinacol ester. This takes place using K2CO3 in DMSO/water to get a biphenyl amino acid derivative. The Boc-protected (2R,4S)-5-(biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid is treated with SOCl2 in EtOH to form the ethyl ester and deprotect the amine. This amine reacts with succinic anhydride to give Sacubitril.

Sacubitril has a molecular formula of C24H29NO5 and a molecular weight of 411.5 g/mol. It appears as a white powder composed of thin hexagonal plates. It features chiral centres at C2 and C11  and a pKa value of 4.6. It has a logP value around 3.8-3.9, making it lipophilic. Its solubility varies from low in 0.1N HCl to high in water. It has a polar surface area of 92.7 Ų with 2 hydrogen bond donors, 4 acceptors, 12 rotatable bonds, and 2 rings supporting oral bioavailability. It rapidly hydrolyses via esterases to active sacubitrilat and forms sodium salt complexes with valsartan in Entresto and stores stably as crystalline Form A.